Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023

Upgrades

According to UBS, the prior rating for Procter & Gamble Co PG was changed from Neutral to Buy. In the second quarter, Procter & Gamble showed an EPS of $1.59, compared to $1.66 from the year-ago quarter. The stock has a 52-week-high of $164.90 and a 52-week-low of $122.18. At the end of the last trading period, Procter & Gamble closed at $137.56.

Roth Capital upgraded the previous rating for Ameresco Inc AMRC from Sell to Neutral. For the fourth quarter, Ameresco had an EPS of $0.35, compared to year-ago quarter EPS of $0.50. The current stock performance of Ameresco shows a 52-week-high of $86.73 and a 52-week-low of $40.73. Moreover, at the end of the last trading period, the closing price was at $43.95.

For Ocugen Inc OCGN, Chardan Capital upgraded the previous rating of Neutral to Buy. Ocugen earned $0.10 in the fourth quarter, compared to $0.07 in the year-ago quarter. The current stock performance of Ocugen shows a 52-week-high of $4.03 and a 52-week-low of $0.93. Moreover, at the end of the last trading period, the closing price was at $1.00.

According to TD Securities, the prior rating for Baytex Energy Corp BTE was changed from Hold to Buy. The stock has a 52-week-high of $4.40 and a 52-week-low of $3.86. At the end of the last trading period, Baytex Energy closed at $3.87.

Benchmark upgraded the previous rating for MKS Instruments Inc MKSI from Hold to Buy. In the fourth quarter, MKS Instruments showed an EPS of $2.00, compared to $3.02 from the year-ago quarter. The stock has a 52-week-high of $163.89 and a 52-week-low of $64.77. At the end of the last trading period, MKS Instruments closed at $96.93.

For Vertex Energy Inc VTNR, Oppenheimer upgraded the previous rating of Perform to Outperform. In the fourth quarter, Vertex Energy showed an EPS of $0.56, compared to $0.15 from the year-ago quarter. The current stock performance of Vertex Energy shows a 52-week-high of $18.10 and a 52-week-low of $5.42. Moreover, at the end of the last trading period, the closing price was at $9.47.

Benchmark upgraded the previous rating for Red Robin Gourmet Burgers Inc RRGB from Hold to Buy. Red Robin Gourmet Burgers earned $1.35 in the fourth quarter, compared to $1.03 in the year-ago quarter. At the moment, the stock has a 52-week-high of $18.64 and a 52-week-low of $5.35. Red Robin Gourmet Burgers closed at $8.51 at the end of the last trading period.

UBS upgraded the previous rating for Ormat Technologies Inc ORA from Neutral to Buy. Ormat Technologies earned $0.73 in the fourth quarter, compared to $0.41 in the year-ago quarter. The current stock performance of Ormat Technologies shows a 52-week-high of $101.81 and a 52-week-low of $67.28. Moreover, at the end of the last trading period, the closing price was at $84.52.

According to Bernstein, the prior rating for Kinder Morgan Inc KMI was changed from Market Perform to Outperform. For the fourth quarter, Kinder Morgan had an EPS of $0.31, compared to year-ago quarter EPS of $0.27. The stock has a 52-week-high of $20.20 and a 52-week-low of $15.78. At the end of the last trading period, Kinder Morgan closed at $17.06.

For Permian Resources Corp PR, Cowen & Co. upgraded the previous rating of Market Perform to Outperform. The current stock performance of Permian Resources shows a 52-week-high of $11.48 and a 52-week-low of $6.12. Moreover, at the end of the last trading period, the closing price was at $10.81.

For Interface Inc TILE, Longbow Research upgraded the previous rating of Neutral to Buy. In the fourth quarter, Interface showed an EPS of $0.31, compared to $0.47 from the year-ago quarter. The current stock performance of Interface shows a 52-week-high of $15.05 and a 52-week-low of $8.43. Moreover, at the end of the last trading period, the closing price was at $8.82.

According to Stifel, the prior rating for Kontoor Brands Inc KTB was changed from Hold to Buy. Kontoor Brands earned $0.88 in the fourth quarter, compared to $0.88 in the year-ago quarter. At the moment, the stock has a 52-week-high of $52.97 and a 52-week-low of $30.98. Kontoor Brands closed at $52.15 at the end of the last trading period.

For TransUnion TRU, Exane BNP Paribas upgraded the previous rating of Neutral to Outperform. For the fourth quarter, TransUnion had an EPS of $0.78, compared to year-ago quarter EPS of $0.81. The current stock performance of TransUnion shows a 52-week-high of $105.00 and a 52-week-low of $50.32. Moreover, at the end of the last trading period, the closing price was at $65.43.

According to Deutsche Bank, the prior rating for Coupang Inc CPNG was changed from Hold to Buy. In the fourth quarter, Coupang showed an EPS of $0.06, compared to $0.23 from the year-ago quarter. The stock has a 52-week-high of $27.12 and a 52-week-low of $8.98. At the end of the last trading period, Coupang closed at $15.51.

UBS upgraded the previous rating for Philip Morris International Inc PM from Neutral to Buy. In the fourth quarter, Philip Morris Intl showed an EPS of $1.39, compared to $1.35 from the year-ago quarter. The current stock performance of Philip Morris Intl shows a 52-week-high of $109.81 and a 52-week-low of $82.85. Moreover, at the end of the last trading period, the closing price was at $97.30.

Morgan Stanley upgraded the previous rating for Sarepta Therapeutics Inc SRPT from Equal-Weight to Overweight. For the fourth quarter, Sarepta Therapeutics had an EPS of $0.53, compared to year-ago quarter EPS of $0.77. The stock has a 52-week-high of $134.08 and a 52-week-low of $61.28. At the end of the last trading period, Sarepta Therapeutics closed at $122.13.

According to JP Morgan, the prior rating for NetEase Inc NTES was changed from Neutral to Overweight. NetEase earned $1.07 in the fourth quarter, compared to $1.56 in the year-ago quarter. The stock has a 52-week-high of $108.77 and a 52-week-low of $53.09. At the end of the last trading period, NetEase closed at $77.64.

See all analyst ratings upgrades.

Downgrades

According to Roth Capital, the prior rating for Ambarella Inc AMBA was changed from Buy to Neutral. Ambarella earned $0.23 in the fourth quarter, compared to $0.45 in the year-ago quarter. At the moment, the stock has a 52-week-high of $143.50 and a 52-week-low of $49.02. Ambarella closed at $94.31 at the end of the last trading period.

According to SVB Leerink, the prior rating for Aptinyx Inc APTX was changed from Outperform to Market Perform. For the third quarter, Aptinyx had an EPS of $0.23, compared to year-ago quarter EPS of $0.31. At the moment, the stock has a 52-week-high of $3.29 and a 52-week-low of $0.19. Aptinyx closed at $0.20 at the end of the last trading period.

According to Northland Capital Markets, the prior rating for Shoals Technologies Group Inc SHLS was changed from Outperform to Market Perform. For the fourth quarter, Shoals Technologies Gr had an EPS of $0.15, compared to year-ago quarter EPS of $0.01. At the moment, the stock has a 52-week-high of $32.43 and a 52-week-low of $9.58. Shoals Technologies Gr closed at $24.54 at the end of the last trading period.

B. Riley Securities downgraded the previous rating for Novavax Inc NVAX from Buy to Neutral. Novavax earned $2.28 in the fourth quarter, compared to $11.18 in the year-ago quarter. At the moment, the stock has a 52-week-high of $91.00 and a 52-week-low of $8.51. Novavax closed at $9.26 at the end of the last trading period.

B. Riley Securities downgraded the previous rating for Century Aluminum Co CENX from Buy to Neutral. In the fourth quarter, Century Aluminum showed an EPS of $0.31, compared to $0.17 from the year-ago quarter. At the moment, the stock has a 52-week-high of $30.36 and a 52-week-low of $5.27. Century Aluminum closed at $12.07 at the end of the last trading period.

According to Citigroup, the prior rating for Warby Parker Inc WRBY was changed from Buy to Neutral. Warby Parker earned $0.00 in the fourth quarter, compared to $0.08 in the year-ago quarter. The stock has a 52-week-high of $36.57 and a 52-week-low of $10.86. At the end of the last trading period, Warby Parker closed at $13.01.

For Universal Health Services Inc UHS, Wolfe Research downgraded the previous rating of Outperform to Peer Perform. In the fourth quarter, Universal Health Servs showed an EPS of $3.02, compared to $2.95 from the year-ago quarter. The current stock performance of Universal Health Servs shows a 52-week-high of $158.28 and a 52-week-low of $82.50. Moreover, at the end of the last trading period, the closing price was at $133.57.

According to JonesTrading, the prior rating for BrightSpire Capital Inc BRSP was changed from Buy to Hold. For the fourth quarter, BrightSpire Capital had an EPS of $0.27, compared to year-ago quarter EPS of $0.27. The current stock performance of BrightSpire Capital shows a 52-week-high of $9.63 and a 52-week-low of $6.11. Moreover, at the end of the last trading period, the closing price was at $7.39.

For Grocery Outlet Holding Corp GO, Craig-Hallum downgraded the previous rating of Buy to Hold. For the fourth quarter, Grocery Outlet Holding had an EPS of $0.25, compared to year-ago quarter EPS of $0.20. The stock has a 52-week-high of $46.37 and a 52-week-low of $26.14. At the end of the last trading period, Grocery Outlet Holding closed at $27.05.

For iHeartMedia Inc IHRT, JP Morgan downgraded the previous rating of Neutral to Underweight. iHeartMedia earned $0.54 in the fourth quarter, compared to $0.76 in the year-ago quarter. The current stock performance of iHeartMedia shows a 52-week-high of $21.53 and a 52-week-low of $5.84. Moreover, at the end of the last trading period, the closing price was at $7.26.

According to Cowen & Co., the prior rating for SM Energy Co SM was changed from Outperform to Market Perform. For the fourth quarter, SM Energy had an EPS of $1.29, compared to year-ago quarter EPS of $1.14. The stock has a 52-week-high of $54.97 and a 52-week-low of $27.92. At the end of the last trading period, SM Energy closed at $29.51.

According to BMO Capital, the prior rating for Builders FirstSource Inc BLDR was changed from Outperform to Market Perform. Builders FirstSource earned $3.21 in the fourth quarter, compared to $2.78 in the year-ago quarter. At the moment, the stock has a 52-week-high of $86.26 and a 52-week-low of $48.91. Builders FirstSource closed at $84.78 at the end of the last trading period.

For Marqeta Inc MQ, JP Morgan downgraded the previous rating of Overweight to Neutral. For the fourth quarter, Marqeta had an EPS of $0.05, compared to year-ago quarter EPS of $0.07. At the moment, the stock has a 52-week-high of $12.41 and a 52-week-low of $5.64. Marqeta closed at $5.80 at the end of the last trading period.

RBC Capital downgraded the previous rating for First Advantage Corp FA from Outperform to Sector Perform. First Advantage earned $0.30 in the fourth quarter, compared to $0.31 in the year-ago quarter. At the moment, the stock has a 52-week-high of $21.01 and a 52-week-low of $10.07. First Advantage closed at $14.51 at the end of the last trading period.

According to Bernstein, the prior rating for Spirit AeroSystems Holdings Inc SPR was changed from Outperform to Market Perform. In the fourth quarter, Spirit AeroSystems Hldgs showed an EPS of $1.46, compared to $0.84 from the year-ago quarter. At the moment, the stock has a 52-week-high of $52.03 and a 52-week-low of $21.14. Spirit AeroSystems Hldgs closed at $34.18 at the end of the last trading period.

JonesTrading downgraded the previous rating for New York Mortgage Trust Inc NYMT from Buy to Hold. New York Mortgage Trust earned $0.13 in the fourth quarter, compared to $0.06 in the year-ago quarter. The current stock performance of New York Mortgage Trust shows a 52-week-high of $3.75 and a 52-week-low of $2.07. Moreover, at the end of the last trading period, the closing price was at $2.67.

Keefe, Bruyette & Woods downgraded the previous rating for Silvergate Capital Corp SI from Outperform to Market Perform. For the fourth quarter, Silvergate Capital had an EPS of $0.48, compared to year-ago quarter EPS of $0.66. The stock has a 52-week-high of $162.65 and a 52-week-low of $10.81. At the end of the last trading period, Silvergate Capital closed at $13.91.

For Olaplex Holdings Inc OLPX, Goldman Sachs downgraded the previous rating of Buy to Neutral. For the fourth quarter, Olaplex Hldgs had an EPS of $0.07, compared to year-ago quarter EPS of $0.10. At the moment, the stock has a 52-week-high of $18.23 and a 52-week-low of $3.80. Olaplex Hldgs closed at $4.92 at the end of the last trading period.

See all analyst ratings downgrades.

Initiations

For DICE Therapeutics Inc DICE, Cowen & Co. initiated coverage, by setting the current rating at Outperform. In the third quarter, DICE Therapeutics showed an EPS of $0.55, compared to $2.15 from the year-ago quarter. The stock has a 52-week-high of $45.99 and a 52-week-low of $12.63. At the end of the last trading period, DICE Therapeutics closed at $29.84.

JP Morgan initiated coverage on Eve Holding Inc EVEX with an Overweight rating. The price target for Eve Holding is set to $8.00. In the third quarter, Eve Holding showed an EPS of $0.14, compared to $0.02 from the year-ago quarter. At the moment, the stock has a 52-week-high of $13.34 and a 52-week-low of $5.30. Eve Holding closed at $5.46 at the end of the last trading period.

With an Overweight rating, Wells Fargo initiated coverage on Columbia Banking System Inc COLB. The price target seems to have been set at $37.00 for Columbia Banking System. In the fourth quarter, Columbia Banking System showed an EPS of $0.88, compared to $0.55 from the year-ago quarter. The stock has a 52-week-high of $36.68 and a 52-week-low of $26.97. At the end of the last trading period, Columbia Banking System closed at $29.73.

With a Neutral rating, DA Davidson initiated coverage on Palantir Technologies Inc PLTR. The price target seems to have been set at $8.00 for Palantir Technologies. Palantir Technologies earned $0.04 in the fourth quarter, compared to $0.02 in the year-ago quarter. At the moment, the stock has a 52-week-high of $14.86 and a 52-week-low of $5.84. Palantir Technologies closed at $7.84 at the end of the last trading period.

Guggenheim initiated coverage on SCYNEXIS Inc SCYX with a Buy rating. The price target for SCYNEXIS is set to $8.00. In the third quarter, SCYNEXIS showed an EPS of $0.62, compared to $0.06 from the year-ago quarter. The current stock performance of SCYNEXIS shows a 52-week-high of $5.15 and a 52-week-low of $1.42. Moreover, at the end of the last trading period, the closing price was at $1.49.

Guggenheim initiated coverage on Calliditas Therapeutics AB CALT with a Neutral rating. The price target for Calliditas Therapeutics is set to $18.00. For the fourth quarter, Calliditas Therapeutics had an EPS of $0.01, compared to year-ago quarter EPS of $0.47.

With a Buy rating, Guggenheim initiated coverage on Chinook Therapeutics Inc KDNY. The price target seems to have been set at $43.00 for Chinook Therapeutics. Chinook Therapeutics earned $0.90 in the fourth quarter, compared to $0.14 in the year-ago quarter. The current stock performance of Chinook Therapeutics shows a 52-week-high of $27.44 and a 52-week-low of $11.81. Moreover, at the end of the last trading period, the closing price was at $21.82.

With a Buy rating, Guggenheim initiated coverage on Aerovate Therapeutics Inc AVTE. The price target seems to have been set at $36.00 for Aerovate Therapeutics. In the third quarter, Aerovate Therapeutics showed an EPS of $0.56, compared to $0.26 from the year-ago quarter. The current stock performance of Aerovate Therapeutics shows a 52-week-high of $30.79 and a 52-week-low of $9.12. Moreover, at the end of the last trading period, the closing price was at $24.57.

Guggenheim initiated coverage on Gossamer Bio Inc GOSS with a Neutral rating. For the third quarter, Gossamer Bio had an EPS of $0.65, compared to year-ago quarter EPS of $0.80. The current stock performance of Gossamer Bio shows a 52-week-high of $15.20 and a 52-week-low of $1.57. Moreover, at the end of the last trading period, the closing price was at $1.73.

With a Buy rating, Guggenheim initiated coverage on ANI Pharmaceuticals Inc ANIP. The price target seems to have been set at $55.00 for ANI Pharmaceuticals. ANI Pharmaceuticals earned $0.64 in the third quarter, compared to $1.01 in the year-ago quarter. The current stock performance of ANI Pharmaceuticals shows a 52-week-high of $45.99 and a 52-week-low of $22.31. Moreover, at the end of the last trading period, the closing price was at $41.84.

Guggenheim initiated coverage on Johnson & Johnson JNJ with a Neutral rating. The price target for Johnson & Johnson is set to $161.00. For the fourth quarter, Johnson & Johnson had an EPS of $2.35, compared to year-ago quarter EPS of $2.13. The current stock performance of Johnson & Johnson shows a 52-week-high of $186.69 and a 52-week-low of $153.04. Moreover, at the end of the last trading period, the closing price was at $153.26.

With a Buy rating, Guggenheim initiated coverage on AbbVie Inc ABBV. The price target seems to have been set at $172.00 for AbbVie. AbbVie earned $3.60 in the fourth quarter, compared to $3.08 in the year-ago quarter. The stock has a 52-week-high of $175.91 and a 52-week-low of $134.09. At the end of the last trading period, AbbVie closed at $153.90.

Guggenheim initiated coverage on Travere Therapeutics Inc TVTX with a Buy rating. The price target for Travere Therapeutics is set to $37.00. Travere Therapeutics earned $0.76 in the fourth quarter, compared to $0.61 in the year-ago quarter. The current stock performance of Travere Therapeutics shows a 52-week-high of $30.35 and a 52-week-low of $17.82. Moreover, at the end of the last trading period, the closing price was at $22.16.

See all analyst ratings initiations.